Meet Karen Carter: The First Black and Female CEO Leading Dow Inc.’s Turnaround
According to financial earnings disclosures and interviews published by Fortune, the 20% jump in net sales unfolded as Carter executed a sweeping restructuring strategy amid global oil market volatility and supply chain disruptions.
Taking the helm July 1 after more than three decades with the firm, Carter oversees a transformation plan launched in January to combat previous financial losses. Last year, the chemical producer recorded an annual net loss of approximately $1.5 billion, followed by a $445 million net income loss in the first quarter of 2026. To reverse those declines, Dow committed to shedding 4,500 positions—a workforce reduction effort currently 55% complete—while closing economically disadvantaged facilities in the United Kingdom and Germany.
Geographic footprint advantages heavily influenced the financial recovery. Per company earnings data, roughly 60% of Dow’s operations are anchored in the Americas. While Asian and European manufacturing hubs rely heavily on crude oil-based naphtha—a feedstock pushed to expensive highs by the Iran conflict and resulting Strait of Hormuz oil shocks—North American operations utilize domestically produced, affordable ethane and propane from the regional shale natural gas boom.
“Our footprint is advantaged on the ethylene and polyethylene side because it is based on ethane, where that price has remained pretty stable,” Carter told Fortune regarding the production of fundamental plastics. “For much of the rest of our portfolio, we continue to lean into those higher-value and higher-growth applications, like data centers.”
Capitalizing on Artificial Intelligence and Pharmaceutical Shocks
Beyond traditional base chemicals, Dow is targeting emerging high-margin sectors. In May, the firm introduced the Dow Coolant Care Network, deploying thermal management products such as DowFrost to maintain energy efficiency in booming AI data center infrastructure. Simultaneously, the downstream ripples of GLP-1 weight-loss medications have expanded chemical demand for related pharmaceutical components, including laxatives like MiraLAX.
Despite these revenue drivers, cautious guidance regarding Middle Eastern geopolitical tensions caused Dow’s stock value to dip slightly following the earnings release. Supply chain uncertainties continue to affect packaging, construction inputs, and industrial materials worldwide. Strategic investments persist despite headwinds, highlighted by construction progress on a $7.5 billion net-zero petrochemical facility in Fort Saskatchewan, Alberta.
Accelerating Turnaround Goals Ahead of Schedule
Market projections originally indicated that the global industrial downturn would persist through 2026, with the worldwide plastics oversupply extending toward 2030, according to corporate disclosures. However, accelerated plant closures in Europe and Asia, paired with potential delays in Middle Eastern production expansions, have shortened the timeline for market rebalancing.
“There are some things that we have to change,” Carter stated in her earnings address. “We have to be more agile; we have to be more resilient; we need to be leaner as we go forward. That’s why the transformation work is so important.”